Ambipar Market Capitalization from 2010 to 2024
| AMBI Stock | USD 5.09 0.07 1.36% |
Check Ambipar Emergency financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ambipar Emergency's main balance sheet or income statement drivers, such as Other Operating Expenses of 2.3 B, Net Income Applicable To Common Shares of 93.3 M or Tax Provision of 52.6 M, as well as many indicators such as Price To Sales Ratio of 0.77, Dividend Yield of 0.0143 or PTB Ratio of 1.87. Ambipar financial statements analysis is a perfect complement when working with Ambipar Emergency Valuation or Volatility modules.
Ambipar | Market Capitalization |
Latest Ambipar Emergency's Market Capitalization Growth Pattern
Below is the plot of the Market Cap of Ambipar Emergency Response over the last few years. It is Ambipar Emergency's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Ambipar Emergency's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 318.59 M | 10 Years Trend |
|
Market Cap |
| Timeline |
Ambipar Market Capitalization Regression Statistics
| Arithmetic Mean | 2,605,027,691 | |
| Geometric Mean | 2,600,458,079 | |
| Coefficient Of Variation | 5.84 | |
| Mean Deviation | 66,164,334 | |
| Median | 2,610,184,038 | |
| Standard Deviation | 152,235,074 | |
| Sample Variance | 23175.5T | |
| Range | 691M | |
| R-Value | (0.07) | |
| Mean Square Error | 24823T | |
| R-Squared | 0.01 | |
| Significance | 0.79 | |
| Slope | (2,505,920) | |
| Total Sum of Squares | 324457.2T |
Ambipar Market Capitalization History
About Ambipar Emergency Financial Statements
Investors use fundamental indicators, such as Ambipar Emergency's Market Capitalization, to determine how well the company is positioned to perform in the future. Although Ambipar Emergency's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Ambit Biosciences Corporationration, a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of oncology, autoimmune, and inflammatory diseases in the United States.
Currently Active Assets on Macroaxis
When determining whether Ambipar Emergency offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ambipar Emergency's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ambipar Emergency Response Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ambipar Emergency Response Stock:Check out the analysis of Ambipar Emergency Correlation against competitors. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Environmental & Facilities Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ambipar Emergency. If investors know Ambipar will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ambipar Emergency listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.422 | Earnings Share 0.25 | Revenue Per Share 133.296 | Quarterly Revenue Growth 0.21 | Return On Assets 0.071 |
The market value of Ambipar Emergency is measured differently than its book value, which is the value of Ambipar that is recorded on the company's balance sheet. Investors also form their own opinion of Ambipar Emergency's value that differs from its market value or its book value, called intrinsic value, which is Ambipar Emergency's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ambipar Emergency's market value can be influenced by many factors that don't directly affect Ambipar Emergency's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ambipar Emergency's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ambipar Emergency is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ambipar Emergency's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.